基本分析
透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。
基本資料
個股的基本資料,以及所屬的類股和產業。
公司介紹
業務介紹
愛德華茲生命科學公司在美國、歐洲、日本和國際上提供用於結構性心臟病、重症監護和手術監測的產品和技術。它提供經導管心臟瓣膜置換產品,用於最小創傷性置換心臟瓣膜;以及經導管心臟瓣膜修復和置換產品,用於治療二尖瓣和三尖瓣疾病。該公司還提供PASCAL和Cardioband經導管瓣膜修復系統,用於最小創傷性治療。此外,它提供外科結構性心臟解決方案,如INSPIRIS名下的主動脈外科瓣膜;KONECT RESILIA,一種預組裝的主動脈組織瓣膜導管,用於需要置換瓣膜、根部和升主動脈的患者;以及HARPOON Beating Heart二尖瓣修復系統,用於患有退行性二尖瓣返流的患者。此外,該公司提供重症監護解決方案,包括先進的血流動力學監測系統,用於測量患者在手術和重症監護環境中的心臟功能和液體狀態;以及Acumen低血壓預測指數軟件,可提前警示臨床醫生患者出現危險性低血壓。該公司通過直銷團隊和獨立經銷商分銷其產品。愛德華茲生命科學公司成立於1958年,總部位於加利福尼亞州欣特維爾。
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。